CureVac Logo mit Claim RGB.jpg
CureVac to Present CV8102 Data at SITC Conference
October 24, 2019 07:00 ET | CureVac AG
TÜBINGEN, Germany and BOSTON, Oct. 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that it will...
CureVac Logo mit Claim RGB.jpg
CureVac Enters into an Exclusive Collaborative Research Agreement for Discovery Research in mRNA-based Lung Therapy Candidates with Yale University
August 13, 2019 07:00 ET | CureVac AG
TÜBINGEN, Germany and BOSTON, Aug. 13, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced today it has entered...
CureVac Logo mit Claim RGB.jpg
CureVac schließt exklusive Forschungskooperation mit der Yale-Universität zur Erforschung mRNA-basierter Arzneimittelkandidaten für die Behandlung von Lungenerkrankungen
August 13, 2019 07:00 ET | CureVac AG
TÜBINGEN, Deutschland / BOSTON, MA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Das biopharmazeutische Unternehmen CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, gab heute den...
CureVac Logo mit Claim RGB.jpg
CureVac to Participate in Two Panels at the ROTH RNA Revolution Conference
July 12, 2019 07:00 ET | CureVac AG
TÜBINGEN, Germany and BOSTON, July 12, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan...
CureVac Logo mit Claim RGB.jpg
CureVac nimmt an zwei Panels der ROTH RNA Revolution Conference teil
July 12, 2019 07:00 ET | CureVac AG
TÜBINGEN, Deutschland / BOSTON, MA, July 12, 2019 (GLOBE NEWSWIRE) -- Dan Menichella, der Vorstandsvorsitzende der CureVac AG, und Dimitris Voliotis, der Chief Development Officer des...
CureVac Logo mit Claim RGB.jpg
European Commission Appoints CureVac Co-Founder & Supervisory Board Chairman, Ingmar Hoerr, to the European Innovation Council Advisory Board
July 01, 2019 07:00 ET | CureVac AG
TÜBINGEN, Germany and BOSTON, July 01, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, congratulates CureVac...
CureVac Logo mit Claim RGB.jpg
Die Europäische Kommission beruft Ingmar Hoerr, Mitgründer und Aufsichtsratsvorsitzender von CureVac, zum Beirat des Europäischen Innovationsrats
July 01, 2019 07:00 ET | CureVac AG
TÜBINGEN, Deutschland und BOSTON, July 01, 2019 (GLOBE NEWSWIRE) -- Die CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, gratuliert CureVacs Mitgründer und...
CureVac Logo mit Claim RGB.jpg
CureVac Welcomes Two Members to its Supervisory Board
June 24, 2019 07:00 ET | CureVac AG
TÜBINGEN, Germany and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that Timothy Wright,...
CureVac Logo mit Claim RGB.jpg
Zwei neue Aufsichtsratsmitglieder bei CureVac
June 24, 2019 07:00 ET | CureVac AG
TÜBINGEN/BOSTON, MA, June 24, 2019 (GLOBE NEWSWIRE) -- Die CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, hat mitgeteilt, dass Timothy Wright M. D. und Craig Tooman...
CureVac Logo mit Claim RGB.jpg
CureVac Receives Grants for Three Patents Regarding Intratumoral Application of RNA
June 13, 2019 07:00 ET | CureVac AG
TÜBINGEN, Germany and BOSTON, June 13, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that it received a...